Pharmaceutical Industry News Archive
Get news By email or subscribe to our News feeds.
July 2009
July 1
Biogen Idec and Acorda Therapeutics Announce Collaboration Agreement to Develop and Commercialize MS Therapy Fampridine-SR in Markets Outside the U.S.
Maxygen Announces Joint Venture with Astellas to Develop Protein Pharmaceuticals
CombinatoRx and Neuromed Sign Merger Agreement
Iressa (Gefitinib) Receives Marketing Authorisation for the Treatment of Non-Small Cell Lung Cancer in Europe
Eisai and Pfizer Decide not to Appeal NICE Decision and Call for an Expedited Review of Guidance for Alzheimer's Disease
Roche Launches Novel Program to Ease Tamiflu Access to Developing Economies
Pfizer Updates Chantix (varenicline) Labeling in the United States
Charles River Announces RMS Succession Plan and Organizational Enhancements
July 2
Bayer Files Patent Infringement Lawsuit Against Teva
Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment
Current Status of the Development Programs of New Indications and Formulations for Aricept for Enhancing Patient Value
GSK Further Extends its Product Portfolio in the Middle East and North Africa
Alcon Discontinues Development of Anecortave Acetate for Intraocular Pressure Reduction
July 6
July 7
SDI Reports: Sanofi-aventis U.S. Joins Ranks of Merck and GlaxoSmithKline as Three Companies Most Respected by Pediatricians, According to SDI Pharmaceutical Company Image Study
European Prices of 170 Best-Selling Drugs Averaged 40 Percent Less Than U.S. Prices in 2008
Caraco Pharmaceutical Laboratories, Ltd. Announces an Indefinite Reduction in its Workforce
Thallion Suspends Patient Enrollment of TLN-232 Metastatic Melanoma Trial Over Licensing Dispute
Teva Provides Update on Generic Ortho Tri-Cyclen Lo
NexMed Announces Decision for Anti-Fungal Product
July 8
Biogen Idec Receives Fast Track Designation from FDA for PEGylated Interferon Beta-1a for Relapsing Multiple Sclerosis
Verilogue Study of More Than 20,000 Real-Life Patient-Physician Interactions Reveals Patients' Top Health-Related Fears
Sermo Survey of US Physicians Indicates AMA No Longer Represents Them
12th Annual Survey on Consumer Reaction to DTC Advertising of Prescription Drugs Reveals: Nearly 50% of Online Consumers Report Health Videos a Top Resource
Japanese Ministry of Health approves Rasilez, a first-in-class direct renin inhibitor (DRI), for the treatment of high blood pressure
July 9
ICON Acquires Veeda Laboratories Limited
EU: Antitrust: Shortcomings in Pharmaceutical Sector Require Further Action
New Senate Biosimilars Proposal Would Jeopardize New Medical Advancements and Cures
NICE Upholds GSK Appeal for Advanced Breast Cancer Treatment, Tyverb (lapatinib)
WHO Grants Prequalification to Cervarix
MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration
Pfizer To Appeal Canadian Federal Court Decision On Company's Norvasc Patent
ratiopharm Canada wins important patent legal battle with Pfizer
July 10
Asmanex (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients
Remeron Now Approved in Japan for the Treatment of Depression in Adult Patients
Forest Laboratories and H. Lundbeck A/S Enter Into Settlement Agreement With Sun and Caraco Related to Lexapro Patent Litigation
Caraco Pharmaceutical Laboratories, Ltd. Enters Into Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro (escitalopram oxalate) ANDA Patent Litigation
Sciele Pharma, a Shionogi Company, Terminates Agreement to Acquire Victory Pharma, Inc.
Alimta (pemetrexed for injection) First Agent Approved in Europe as Maintenance Therapy for Advanced, Nonsquamous Non-Small Cell Lung Cancer
July 14
July 15
FDA Requires Labeling Change for Some Drugs Used to Prevent Rejection of Kidney Transplants
Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009
Hormone Therapy Use Associated With Increased Risk of Ovarian Cancer
Expert Statement Issued about Lantus Following Recent Publications in Diabetologia
FDA Sends Warning Letter to Apotex
Merck and Schering-Plough Resolve Previously Disclosed Investigation Under State Consumer Protection Statutes Related to VYTORIN(ezetimibe/simvastatin) and ZETIA (ezetimibe)
July 16
Baxter Reports Strong Second Quarter 2009 Financial Results and Raises Full-Year Outlook
Phillip A. Sharp to Retire from Biogen Idec Board
Biogen Idec Reports Second Quarter 2009 Results
Novartis Delivers Strong Operational Performance In The First Half Of 2009 Driven By Sustained Pharmaceuticals Innovation
PharmaTelevision Launches New Premium Content Service
July 17
Biopure Files Voluntary Petition for Relief Under Chapter 11 of the United States Bankruptcy Code
FDA Reviewing Preliminary Safety Information on Asthma Drug Xolair
Luna Innovations Files for Chapter 11 Reorganization
Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada With Gilead Sciences
Pro-Pharmaceuticals Prevails in Trade Secret Lawsuit
July 21
Merck Announces Second-Quarter 2009 Financial Results
Schering-Plough Reports Financial Results for 2009 Second Quarter
Elan Reports Second Quarter 2009 Financial Results
FDA Approves Vaccine for 2009-2010 Seasonal Influenza
Forest Laboratories, Inc. Reports Fiscal First Quarter 2010 Earnings Per Share of $0.87
EPIX Pharmaceuticals Assigns All of Its Assets for the Benefit of Creditors
Ontario, Canada Leading World-Class Research on New Cancer Drugs
July 22
DellaCamera Advised That Enzon Has Set July 24, 2009 as Record Date for Consent Solicitation
Pfizer Reports Second-Quarter 2009 Results; Increases Full-Year 2009 Adjusted Diluted EPS(1) Guidance
Gilead Sciences Announces Record Second Quarter 2009 Financial Results
Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance
SEC Charges Perry Corp. With Disclosure Violations in Vote Buying Scheme
Vaxine Wins Line Honours With World's First Human Swine Flu Vaccine
July 23
Bristol-Myers Squibb to Acquire Medarex
Alcon and AstraZeneca to Collaborate on Eye Drug Development
Large Pharmaceutical Firms Are Getting More Drugs Into Development While Terminating Unpromising Candidates
Excellent Performance Highlights Second Quarter for Bristol-Myers Squibb
Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance
Double-digit increase in sales, operating profit1 and Core EPS
JMI Launches Specialty, Professional and Social Networking Site for Pharmacy Industry
July 24
July 27
July 28
Good First Six Months In 2009 For Boehringer Ingelheim - Successful Products Spiriva®, Micardis And Flomax Secure Good Growth
Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement
Bristol-Myers Squibb Begins Tender Offer to Acquire Medarex, Inc.
Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO)
Mylan Reports That the FDA Determined That All Accusations Were Unfounded
NHLBI Stops Study Of Treatment For Pulmonary Hypertension In Patients With Sickle Cell Disease Due To Safety Concerns
Insmed Provides Update on Supply of Iplex
July 29
July 30
Sanofi-aventis to Acquire Merck's Interest in Merial
H. Lundbeck A/S (DK) - Pipeline update - following an interim analysis the studies with bifeprunox for the treatment of schizophrenia is discontinued
Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009
AstraZeneca PLC: Second Quarter And Half Year Results 2009
Pfizer, Kano State Reach Settlement Of Trovan Cases
July 31
Accreditation Council for Continuing Medical Education Chief Executive Testifies at Senate Hearing
Genzyme Corporation (GENZ) Target of Investigation for Potential Securities Law Violations, Hagens Berman Announces
Lilly Announces Continued Commitment to Transparency with Faculty Registry
Genzyme Provides Update on Allston Landing Plant
Ligand and Organon Mutually Terminate Collaboration and License Agreement
Averion Announces Organizational Realignment
